NDAINHALATIONAEROSOL, METERED
Approved
Jun 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
4/8 — Partial
Drug data last refreshed 1h ago · AI intelligence enriched 1h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ADVAIR HFA is a fixed-dose combination inhaler containing fluticasone propionate (inhaled corticosteroid) and salmeterol xinafoate (long-acting beta-2 agonist) delivered via metered-dose aerosol. It is indicated for maintenance treatment of asthma and COPD in patients requiring both anti-inflammatory and bronchodilator therapy. The combination works by reducing airway inflammation while simultaneously dilating airways to improve breathing.
$398MPart D
LOE ApproachingApproaching loss of exclusivity with significant Medicare utilization (651K claims, $398M spending) signals transition from growth to lifecycle management requiring focused cost-containment and patient retention strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
Advair HFA in Healthy and HAPE Predisposed Subjects
Started Dec 2023
60 enrolled
Altitude Edema
Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)
Started Mar 2008
247 enrolled
Pulmonary Disease, Chronic Obstructive
A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS
Started Oct 2006
28 enrolled
Asthma
Why This Matters for Your Career
Worked on ADVAIR HFA at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.